Raymond James & Associates’s Moleculin Biotech MBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-945	Closed	-$43K	–	4038
2021 Q3	$43K	Sell	945 -54	-5%	-$2.46K	﹤0.01%	3854
2021 Q2	$55K	Hold	999	–	–	﹤0.01%	3835
2021 Q1	$61K	Buy	+999	New	+$61K	﹤0.01%	3757